Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07615816 · ClinicalTrials.gov registry record · NA
Investigating Medical Massage Therapy for Patients With Sub-Acute Lower Back Pain
A NA study, sponsored by The Geneva Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 220
- Enrollment target
NCT07615816: Recruiting NA study, sponsored by The Geneva Foundation.
NCT07615816 is a NA study that is actively recruiting participants, run by The Geneva Foundation. The registered enrollment target is 220 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07615816, a NA study, is actively recruiting participants, sponsored by The Geneva Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to determine if a weekly regimen of Medical Massage Therapy (MMT) with provider-directed care shortens the duration of Medically Restricted Duty Days (MRDD) periods in Active-Duty Service Members with Subacute Lower Back Pain (LBP) compared to provider-directed care alone. The main question the study aims to answer is, when used as an adjunct to provider-directed care, a consistent program of MMT provided by a qualified practitioner, will shorten the duration of MRDD periods, reduce pain, and decrease unnecessary healthcare utilization in patients with Subacute LBP compared to provider-directed care alone. Researchers will study this hypothesis through the comparison of Group #1 (provider-directed care alone) and Group #2 (provider-directed care and MMT). Participants randomized into the two study groups will be following a 12-week study design (+/- 2 weeks) comprised of their compliance to their provider-directed care, the study intervention (if randomized to Group #2) and study case report forms (CRFs); with a final follow up visit (up to 4 weeks following their final treatment visit).
Primary Outcome
The M-ODI is the most commonly used aid for evaluating disability due to LBP This free instrument delivers medical provider information related to functional limitation and pain management.
Interventions
- PROCEDURE Medical Massage Therapy
- OTHER Provider Directed Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What NCT07615816 shows while recruiting
NCT07615816 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 2 interventions - of which Medical Massage Therapy is the first listed.
NCT07615816 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07615816 about?
NCT07615816 is a clinical study titled "Investigating Medical Massage Therapy for Patients With Sub-Acute Lower Back Pain". The goal of this clinical trial is to determine if a weekly regimen of Medical Massage Therapy (MMT) with provider-directed care shortens the duration of Medically Restricted Duty Days (MRDD) periods in Active-Duty Service Members with Subacute Lower Back Pain (LBP) compared to provider-directed car...
What is the current status of trial NCT07615816?
This trial is currently recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2026-06-01. Estimated completion is 2027-01-31.
What interventions are being tested in trial NCT07615816?
The interventions under investigation include: Medical Massage Therapy (PROCEDURE), Provider Directed Care (OTHER).
Who is sponsoring clinical trial NCT07615816?
This trial is sponsored by The Geneva Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07615816's enrollment target sits among peer trials
220 481st of 2000 higher than 1,516 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI